Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Doylestown
State: Pennsylvania
Zip:
Country: United States
Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2013 | Series A | $0 |
Medical Marijuana Inc. CannaVest CannaVest Medical Marijuana Inc. Medical Marijuana Inc. CannaVest CannaVest Medical Marijuana Inc. |
5/2015 | Venture Round | - | 9/2021 | Grant | 1 | $3M |
National Institute of Neurological Disorders and Stroke National Institute of Neurological Disorders and Stroke |
5/2015 | Venture Round | - | 3/2013 | Series A | 2 | $1.5M |
Medical Marijuana Inc. CannaVest CannaVest Medical Marijuana Inc. Medical Marijuana Inc. CannaVest CannaVest Medical Marijuana Inc. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|